Peptides in Major Psychoses
During the last decades, biological interest in depression has focused on neuroendocrinological disturbances. Accordingly the involvement of minor peptide hormones present in the brain have been hypothesized and studied. Thus an impaired thyrotropin (TSH) response to thyrotropin releasing hormone (TRH) has been described (Prange et al., 1972; Kastin et al., 1972), and furthermore Kirkegaard et al. (1975) and Kirkegaard and Smith (1978) showed that changes in TSH response to TRH during electroconvulsive therapy (ECT) seem to be of predictive value for the post-treatment course of the disease. Moreover, Kirkegaard et al. (1979), reported high levels of TRH in cerebrospinal fluid (CSF) in endogenous depression.
KeywordsGrowth Hormone Schizophrenic Patient Vasoactive Intestinal Polypeptide Thyrotropin Release Hormone Electroconvulsive Therapy
Unable to display preview. Download preview PDF.
- Gjerris, A., Fahrenkrug, J., Bojholm, S., and Rafaelsen, O. J., 1981, Vasoactive Intestinal Polypeptide (VIP) in cerebrospinal fluid in psychiatric disorders, in: “Biological Psychiatry”, C. Perris, G. Struwe, and B. Jansson, eds., Elsevier/Borth-Holland Biomedical Press, Amsterdam, 565.Google Scholar
- Gjerris, A., Rafaelsen, O.J., Vendsborg, P., and Rehfeld, J.,1983,Gastrointestinal peptides in cerebrospinal fluid in psychiatric disorders, J Affective Pis, to be published.Google Scholar
- Johansson, B.B., Fahrenkrug, J., Wikkelso, C., Andersen, O., and Blomstrand, C., 1982, Vasoactive intestinal polypeptide in human cerebrospinal fluid, Front Horm Res, 9:189.Google Scholar